Ausschreibungen im Cluster Gesundheit

Hier finden Sie alle Ausschreibungen, die im Arbeitsprogramm des Clusters Gesundheit veröffentlicht werden.

Person in weißem Kittel hält Stethoskop und Tabletcomputer, davor schweben Symbole zum Thema Vernetzung — sasun Bughdaryan - stock.adobe.com

Das Arbeitsprogramm des Clusters Gesundheit mit den Ausschreibungsthemen für 2025 wurde von der Europäischen Kommission am 14. Mai 2025 veröffentlicht.

♦ Arbeitsprogramm 2025 des Clusters Gesundheit

Das Arbeitsprogramm im Cluster Gesundheit ist entlang sechs Destinations – oder Zielpunkten – gegliedert:

Destination 1 – Gesund bleiben in einer sich schnell verändernden Gesellschaft
Destination 2 – Leben und Arbeiten in einem gesundheitsfördernden Umfeld
Destination 3 – Bekämpfung von Krankheiten und Verringerung der Krankheitslast
Destination 4 – Sicherstellung des Zugangs zu innovativer, nachhaltiger und qualitativ hochwertiger Gesundheitsversorgung
Destination 5 – Erschließung des vollen Potenzials neuer Werkzeuge, Technologien und digitaler Lösungen für eine gesunde Gesellschaft
Destination 6 – Aufrechterhaltung einer innovativen, nachhaltigen und global wettbewerbsfähigen gesundheitsbezogenen Industrie

Zusätzlich zu den Ausschreibungen im Cluster Gesundheit bietet die Europäische Kommission auch Fördermöglichkeiten zur onkologischen Forschung an. Diese sind zum größten Teil im Bereich der Krebsmission angesiedelt. Offene Ausschreibungen im Rahmen der Krebsmission finden Sie auf unserer Website: Aktuelle Ausschreibungen - Mission Krebs

Aktuelle Ausschreibungen im Cluster Gesundheit nach Destination:

Seite "Destination 1 - Topic 1: Improving the quality of life of persons with intellectual disabilities and their families (RIA)" öffnen

22.05.2025 - 16.04.2026

Ausschreibung (zweistufig)

Destination 1 - Topic 1: Improving the quality of life of persons with intellectual disabilities and their families (RIA)

Seite "Destination 2 - Topic 1: The impact of pollution on the development and progression of brain diseases and disorders (RIA)" öffnen

22.05.2025 - 16.04.2026

Ausschreibung (zweistufig)

Destination 2 - Topic 1: The impact of pollution on the development and progression of brain diseases and disorders (RIA)

Seite "Destination 2 - Topic 2: Advancing knowledge on the impacts of micro- and nanoplastics on human health (RIA)" öffnen

22.05.2025 - 16.04.2026

Ausschreibung (zweistufig)

Destination 2 - Topic 2: Advancing knowledge on the impacts of micro- and nanoplastics on human health (RIA)

Seite "Destination 3 - Topic 1: Testing safety and efficacy of phage therapy for the treatment of antibiotic-resistant bacterial infections (RIA)" öffnen

22.05.2025 - 16.09.2025

Ausschreibung (einstufig)

Destination 3 - Topic 1: Testing safety and efficacy of phage therapy for the treatment of antibiotic-resistant bacterial infections (RIA)

Seite "Destination 3 - Topic 7: Advancing innovative interventions for mental, behavioural and neurodevelopmental disorders (RIA)" öffnen

22.05.2025 - 16.04.2026

Ausschreibung (zweistufig)

Destination 3 - Topic 2: Advancing innovative interventions for mental, behavioural and neurodevelopmental disorders (RIA)

Seite "Destination 3 - Topic 2: Development of antibodies and antibody-derived proteins for the prevention and treatment of infectious diseases with epidemic potential (RIA)" öffnen

22.05.2025 - 16.09.2025

Ausschreibung (einstufig)

Destination 3 - Topic 3: Development of antibodies and antibody-derived proteins for the prevention and treatment of infectious diseases with epidemic potential (RIA)

Seite "Destination 3 - Topic 3: Leveraging artificial intelligence for pandemic preparedness and response (RIA)" öffnen

22.05.2025 - 16.09.2025

Ausschreibung (einstufig)

Destination 3 - Topic 4: Leveraging artificial intelligence for pandemic preparedness and response (RIA)

Seite "Destination 3 - Topic 4: Support for the functioning of the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R) (CSA)" öffnen

22.05.2025 - 16.09.2025

Ausschreibung (einstufig)

Destination 3 - Topic 5: Support for the functioning of the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R) (CSA)

Seite "Destination 3 - Topic 5: Implementation research addressing strategies to strengthen health systems for equitable high-quality care and health outcomes in the context of non-communicable diseases (GACD) (RIA)" öffnen

22.05.2025 - 16.09.2025

Ausschreibung (einstufig)

Destination 3 - Topic 6: Implementation research addressing strategies to strengthen health systems for equitable high-quality care and health outcomes in the context of non-communicable diseases (GACD) (RIA)

Seite "Destination 3 - Topic 6: Tackling high-burden for patients and under-researched medical conditions (RIA)" öffnen

22.05.2025 - 16.09.2025

Ausschreibung (einstufig)

Destination 3 - Topic 7: Tackling high-burden for patients and under-researched medical conditions (RIA)

Seite "Destination 4 - Topic 1: End user-driven application of Generative Artificial Intelligence models in healthcare (GenAI4EU) (RIA)" öffnen

22.05.2025 - 16.09.2025

Ausschreibung (einstufig)

Destination 4 - Topic 1: End user-driven application of Generative Artificial Intelligence models in healthcare (GenAI4EU) (RIA)

Seite "Destination 5 - Topic 1: Enhancing cell therapies with genomic techniques (RIA)" öffnen

22.05.2025 - 16.09.2025

Ausschreibung (einstufig)

Destination 5 - Topic 1: Enhancing cell therapies with genomic techniques (RIA)

Seite "Destination 5 - Topic 2: Advancing cell secretome-based therapies (RIA)" öffnen

22.05.2025 - 16.09.2025

Ausschreibung (einstufig)

Destination 5 - Topic 2: Advancing cell secretome-based therapies (RIA)

Seite "Destination 5 - Topic 3: Leveraging multimodal data to advance Generative Artificial Intelligence applicability in biomedical research (GenAI4EU) (RIA)" öffnen

22.05.2025 - 16.09.2025

Ausschreibung (einstufig)

Destination 5 - Topic 3: Leveraging multimodal data to advance Generative Artificial Intelligence applicability in biomedical research (GenAI4EU) (RIA)

Seite "Destination 5 - Topic 4: Boosting the translation of biotech research into innovative health therapies (RIA)" öffnen

22.05.2025 - 16.09.2025

Ausschreibung (einstufig)

Destination 5 - Topic 4: Boosting the translation of biotech research into innovative health therapies (RIA)

Seite "Destination 6 - Topic 1: Optimising the manufacturing of Advanced Therapy Medicinal Products (ATMPs) (IA)" öffnen

22.05.2025 - 16.09.2025

Ausschreibung (einstufig)

Destination 6 - Topic 1: Optimising the manufacturing of Advanced Therapy Medicinal Products (ATMPs) (IA)

Seite "Destination 6 - Topic 2: Digitalisation of conformity assessment procedures of medical devices and in vitro diagnostic medical devices (CSA)" öffnen

22.05.2025 - 16.09.2025

Ausschreibung (einstufig)

Destination 6 - Topic 2: Digitalisation of conformity assessment procedures of medical devices and in vitro diagnostic medical devices (CSA)

Seite "Destination 6 - Topic 3: Facilitating the conduct of multinational clinical studies of orphan devices and/or of highly innovative (“breakthrough”) devices (RIA)" öffnen

15.05.2025 - 16.04.2026

Ausschreibung (zweistufig)

Destination 6 - Topic 3: Facilitating the conduct of multinational clinical studies of orphan devices and/or of highly innovative (“breakthrough”) devices (RIA)

Mehr laden

Ausschreibungen im Cluster Gesundheit

♦ Arbeitsprogramm 2025 des Clusters Gesundheit

Aktuelle Ausschreibungen im Cluster Gesundheit nach Destination:

Destination 1 - Topic 1: Improving the quality of life of persons with intellectual disabilities and their families (RIA)

Destination 2 - Topic 1: The impact of pollution on the development and progression of brain diseases and disorders (RIA)

Destination 2 - Topic 2: Advancing knowledge on the impacts of micro- and nanoplastics on human health (RIA)

Destination 3 - Topic 1: Testing safety and efficacy of phage therapy for the treatment of antibiotic-resistant bacterial infections (RIA)

Destination 3 - Topic 2: Advancing innovative interventions for mental, behavioural and neurodevelopmental disorders (RIA)

Destination 3 - Topic 3: Development of antibodies and antibody-derived proteins for the prevention and treatment of infectious diseases with epidemic potential (RIA)

Destination 3 - Topic 4: Leveraging artificial intelligence for pandemic preparedness and response (RIA)

Destination 3 - Topic 5: Support for the functioning of the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R) (CSA)

Destination 3 - Topic 6: Implementation research addressing strategies to strengthen health systems for equitable high-quality care and health outcomes in the context of non-communicable diseases (GACD) (RIA)

Destination 3 - Topic 7: Tackling high-burden for patients and under-researched medical conditions (RIA)

Destination 4 - Topic 1: End user-driven application of Generative Artificial Intelligence models in healthcare (GenAI4EU) (RIA)

Destination 5 - Topic 1: Enhancing cell therapies with genomic techniques (RIA)

Destination 5 - Topic 2: Advancing cell secretome-based therapies (RIA)

Destination 5 - Topic 3: Leveraging multimodal data to advance Generative Artificial Intelligence applicability in biomedical research (GenAI4EU) (RIA)

Destination 5 - Topic 4: Boosting the translation of biotech research into innovative health therapies (RIA)

Destination 6 - Topic 1: Optimising the manufacturing of Advanced Therapy Medicinal Products (ATMPs) (IA)

Destination 6 - Topic 2: Digitalisation of conformity assessment procedures of medical devices and in vitro diagnostic medical devices (CSA)

Destination 6 - Topic 3: Facilitating the conduct of multinational clinical studies of orphan devices and/or of highly innovative (“breakthrough”) devices (RIA)

Newsletter

Kontakt zur NKS Gesundheit